Inhibiting induction of heat shock proteins as a strategy to enhance cancer therapy

International Journal of Hyperthermia

Volumn 21, Issue 8, 2005, Pages 695-701

  Coss, Ronald A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Acute acidification; Apoptosis; Cancer therapy; Heat shock proteins; Quercetin

Indexed keywords

HEAT SHOCK PROTEIN;

ACIDIFICATION; APOPTOSIS; CANCER THERAPY; CELL DAMAGE; CONFERENCE PAPER; HUMAN; HYPERTHERMIC THERAPY; IMMUNE RESPONSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

APOPTOSIS; CLINICAL TRIALS; HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTHERMIA, INDUCED; IMMUNE SYSTEM; NEOPLASMS;

EID: 29144485524     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730500331918     Document Type: Conference Paper

References (61)

1. Dewey WC. Failla memorial lecture. The search for critical cellular targets damaged by heat. Radiation Research 1989;120:191-204.
2. Lepock JR. Role of nuclear protein denaturation and aggregation in thermal radiosensitization. International Journal of Hyperthermia 2004;20:115-130.
3. Yatvin MB, Cramp WA. Role of cellular membranes in hyperthermia: Some observations and theories reviewed. International Journal of Hyperthermia 1993;9:165-185.
4. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Natural Reviews in Cancer 2005;5:231-237.
5. Lindquist S, Craig EA. The heat-shock proteins. Annual Reviews in Genetics 1988;22:631-677.
6. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. Journal of the National Cancer Institute 2000;92:1564-1572.
7. Jäättelä M. Escaping cell death: Survival proteins in cancer. Experimental Cell Research 1999;248:30-43.
8. Parcellier A, Gurbuxani S, Schmitt E, Solary E, Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochemistry & Biophysics Research Communications 2003;304:505-512.
9. Beere HM. 'The stress of dying': The role of heat shock proteins in the regulation of apoptosis. Journal of Cell Science 2004;117:2641-2651.
10. van den Berg AP, Wike-Hooley JL, Broekmeyer-Reurink MP, van der Zee J, Reinhold HS. The relationship between the unmodified initial tissue pH of human tumours and the response to combined radiotherapy and local hyperthermia treatment. European Journal of Cancer & Clinical Oncology 1989;25:73-78.
11. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Research 1989;49:6449-6465.
12. Leeper DB, Engin K, Thistlethwaite AJ, Hitchon HD, Dover JD, Li DJ, et al. Human tumor extracellular pH as a function of blood glucose concentration. International Journal of Radiation Oncology, Biology & Physics 1994;8:935-943.
13. Engin K, Leeper DB, Tupchong L, Thistlethwaite A. Tumor pH and response to thermoradiotherapy in superficial human tumors. International Journal of Radiation Oncology, Biology & Physics 1995;29:125-132.
14. Leeper DB, Engin K, Wang JH, Cater JR, Li DJ. Effect of i.v. glucose versus combined i.v. plus oral glucose on human tumour extracellular pH for potential sensitization to thermoradiotherapy. International Journal of Hyperthermia 1998;14:257-269.
15. Han J-S, Storck CW, Wachsberger PR, Leeper DB, Berd D, Wahl ML, et al. Acute extracellular acidification increases nuclear associated protein levels in human melanoma cells during 42°C hyperthermia and enhances cell killing. International Journal of Hyperthermia 2002;18:404-415.
16. Coss RA, Storck CW, Daskalakis C, Berd D, Wahl ML. Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. Molecular Cancer Therapy 2003;2:383-388.
17. Coss RA, Storck CW, Wachsberger PR, Reilly J, Leeper DB, Berd D, et al. Acute extracellular acidification reduces intracellular pH, 42°C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7. International Journal of Hyperthermia 2004;20:93-106.
18. Jahde E, Rajewsky MF. Tumor-selective modification of cellular microenvironment in vivo: Effect of glucose infusion on the pH in normal and malignant rat tissues. Cancer Research 1982;42:1505-1512.
19. Evelhoch JL, Sapareto SA, Jick DE, Ackerman JJ. In vivo metabolic effects of hyperglycemia in murine radiation-induced fibrosarcoma: A 31P NMR investigation. Proceedings of the National Academy of Sciences (USA) 1984;81:6496-6500.
20. Sevic EM, Jain RK. Blood flow and venous pH of tissue-isolated Walker 256 carcinoma during hyperglycemia. Cancer Research 1988;48:1201-1207.
21. Volk T, Jahde E, Fortmeyer HP, Glusenkamp KH, Rajewsky MF. pH in human tumour xenografts: Effect of intravenous administration of glucose. British Journal of Cancer 1993;68:492-500.
22. Jahde E, Volk T, Atema A, Smets LA, Glusenkamp KH, Rajewsky MF. pH in human tumor xenografts and transplanted rat tumors: Effect of insulin, inorganic phosphate, and m-iodobenzylguanidine. Cancer Research 1992;52:6209-6215.
23. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, et al. Regulation of intracellular pH in human melanoma: Potential therapeutic implications. Molecular Cancer Therapy 2002;1:617-628.
24. Burd R, Lavorgna SN, Daskalakis C, Wachsberger PR, Wahl ML, Biaglow JE, et al. Tumor oxygenation and acidification are increased in melanoma xenografts after exposure to hyperglycemia and meta-iodo-benzylguanidine. Radiation Research 2003;159:328-335.
25. Zhou R, Bansal N, Leeper DB, Glickson JD. Enhancement of hyperglycemia-induced acidification of human melanoma xenografts by inhibitors of respiration and ion transport. Acad Radiologica 2001;8:571-582.
26. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nature Cell Biology 2000;21:476-483.
27. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, et al. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Molecular and Cell Biology 2000;20:7146-7159.
28. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nature Cell Biology 2000;2:645-652.
29. Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V, et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. The EMBO Journal 2000;19:4310-4322.
30. Solit DB, Scher HI, Rosen N. Hsp90 as a therapeutic target in prostate cancer. Seminars in Oncology 2003;30:709-716.
31. Grem JL, Morrison G, Guo XD, Agnew E, Takimoto CH, Thomas R, et al. Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors. Journal of Clinical Oncology 2005;23:1885-1893.
32. Goetz MP, Toft D, Reid J, Ames M, Stensgard B, Safgren S, et al. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. Journal of Clinical Oncology 2005;23:1078-1087.
33. Neckers L, Neckers K. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics-an update. Expert Opinions in Emergency Drugs 2005;10:137-149.
34. Maloney A, Workman P. HSP90 as a new therapeutic target for cancer therapy: The story unfolds. Expert Opinions in Biological Therapy 2002;2:3-24.
35. Bagatell R, Paine-Murrieta GD, Taylor CW, Pulcini EJ, Akinaga S, Benjamin IJ, et al. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents. Clinical Cancer Research 2000;6:3312-3318.
36. Whitesell L, Bagatell R, Falsey R. The stress response: Implications for the clinical development of hsp90 inhibitors. Current Cancer Drug Targets 2003;3:349-358.
37. Griffin TM, Valdez TV, Mestril R. Radicicol activates heat shock protein expression and cardioprotection in neonatal rat cardiomyocytes. AJP - Heart 2004;287:1081-1088.
38. Cesario A, Catassi A, Festi L, Imperatori A, Pericelli A, Galetta D, et al. Farnesyltransferase inhibitors and human malignant pleural mesothelioma: A first-step comparative translational study. Clinical Cancer Research 2005;11:2026-2037.
39. Hu W, Wu W, Verschraegen CF, Chen L, Mao L, Yeung SC, et al. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics 2003;3:1904-1911.
40. Hu W, Wu W, Yeung SC, Freedman RS, Kavanagh JJ, Verschraegen CF. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. Anticancer Research 2002;22:665-672.
41. Nagai N, Nakai A, Nagata K. Quercetin suppresses heat shock response by down regulation of HSF1. Biochemistry & Biophysics Research Communications 1995;208:1099-1105.
42. Kim SH, Yeo GS, Lim YS, Kang CD, Kim CM, Chung BS. Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells. Experimental Molecular Medicine 1998;30:87-92.
43. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radical Biology Medicine 2004;36:838-849.
44. Lee YJ, Curetty L, Hou Z, Kim SH, Kim JH, Corry PM. Effect of pH on quercetin-induced suppression of heat shock gene expression and thermotolerance development in HT-29 cells. Biochemistry & Biophysics Research Communications 1992;186:1121-1128.
45. Lee YJ, Erdos G, Hou Z, Kim SH, Kim JH, Cho JM, et al. Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells. Molecular Cell Biochemistry 1994;137:141-154.
46. Wachsberger PR, Burd R, Bhala A, Bobyock SB, Wahl ML, Owen CS, et al. Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia. International Journal of Hyperthermia 2003;19:507-519.
47. Asea A, Ara G, Teicher BA, Stevenson MA, Calderwood SK. Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo. International Journal of Hyperthermia 2001;17:347-356.
48. Jones EL, Zhao MJ, Stevenson MA, Calderwood SK. The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer. International Journal of Hyperthermia 2004;20:835-849.
49. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial. Urology 1999;54:960-963.
50. Shoskes DA. Treatment response to conventional and novel therapies in chronic prostatitis. Current Urology Reports 2003;4:311-315.
51. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. American Journal of Clinical Nutrition 2005;81:230S-242S.
52. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition 2005;81:243S-255S.
53. Yokota S, Kitahara M, Nagata K. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Research 2000;60:2942-2948.
54. Koishi M, Yokota S, Mae T, Nishimura Y, Kanamori S, Horii N, et al. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clinical Cancer Research 2001;7:215-219.
55. Nonaka T, Akimoto T, Mitsuhashi N, Tamaki Y, Yokota S, Nakano T. Changes in the localization of heat shock protein 72 correlated with development of thermotolerance in human esophageal cancer cell line. Anticancer Research 2003;23:4677-4687.
56. Ohnishi K, Takahashi A, Yokota S, Ohnishi T. Effects of a heat shock protein inhibitor KNK437 on heat sensitivity and heat tolerance in human squamous cell carcinoma cell lines differing in p53 status. International Journal of Radiation Biology 2004;80:607-614.
57. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: Short RNAs that silence gene expression. Natural Reviews in Molecular Cell Biology 2003;4:457-467.
58. Bedford JS, Liber HL. Applications of RNA interference for studies in DNA damage processing, genome stability, mutagenesis, and cancer. Seminars in Cancer Biology 2003;13:301-308.
59. Betz N. Technically speaking: RNAi: RNA interference. Promega Notes 2003;83:33-36.
60. Becker B, Multhoff G, Farkas B, Wild PJ, Landthaler M, Stolz W, Vogt T. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Experimental Dermatology 2004;13:27-32.
61. Farkas B, Hantschel M, Magyarlaki M, Becker B, Scherer K, Landthaler M, Pfister K, Gehrmann M, Gross C, Mackensen A, Multhoff G. Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma. Melanoma Research 2003;13:147-152.